IDEAYA Biosciences, Inc.
IDYA
$17.45
-$0.90-4.91%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -82.40% | -283.78% | -88.85% | -88.97% | -67.39% |
| Total Depreciation and Amortization | 4.71% | -37.21% | -1.36% | 9.92% | 12.71% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 323,050.00% | 395.55% | 122.02% | 42.12% | -100.10% |
| Change in Net Operating Assets | 179.76% | -58.30% | 58.56% | 280.26% | 26.75% |
| Cash from Operations | -37.73% | -412.27% | -63.17% | 1.73% | -57.36% |
| Capital Expenditure | -0.38% | -31.50% | 24.21% | -10.07% | -2,981.40% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 123.01% | -76.42% | -137.69% | 157.70% | -1,596.55% |
| Cash from Investing | 122.55% | -76.08% | -139.02% | 156.48% | -1,604.91% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -92.51% | -97.94% | 895.56% | -74.87% | 11,831.34% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | -- | -- | -- |
| Cash from Financing | -92.51% | -98.05% | 929.33% | -79.49% | 11,831.34% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 193.72% | -6,173.63% | 343.27% | 106.66% | -3,389.10% |